⚠️ Disclaimer

Selank is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.

Selank is being researched for brain applications. Allosterically modulates GABAA receptors and inhibits enkephalin-degrading enzymes. Influences dopaminergic and serotonergic systems while enhancing GABA-mediated neurotransmission, producing anxiolyt. Common dosages for this use range from 75-300 mcg 1-3 times daily.

Can Selank Help With Brain?

Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro heptapeptide) is being researched for brain applications based on its mechanism as a Nootropic anxiolytic peptide.

Allosterically modulates GABAA receptors and inhibits enkephalin-degrading enzymes. Influences dopaminergic and serotonergic systems while enhancing GABA-mediated neurotransmission, producing anxiolytic effects comparable to benzodiazepines without receptor downregulation, tolerance, or dependence.

What Does the Research Show for Selank and Brain?

Clinical noninferiority trial in 62 GAD patients showed similar anxiolytic action to medazepam (benzodiazepine). Multiple Russian clinical studies demonstrate efficacy. Evidence base predominantly from Russian institutions.

The relevance to brain specifically comes from Selank's effects on anxiety reduction, cognitive enhancement, stress resilience, benzodiazepine-like anxiolysis without dependence.

What Protocol Is Used for Brain?

For brain applications, the standard Selank protocol is 75-300 mcg administered 1-3 times daily via intranasal spray for 5-21 days with washout periods.

Some researchers adjust dosing based on the specific brain application — see our Selank dosage guide for full protocol details.

Can Stacking Improve Brain Results?

Pairs with Semax for enhanced cognitive and anxiolytic effects through complementary GABAergic/dopaminergic pathways.

What Side Effects Apply to Brain Use?

Well-tolerated. Mild nasal irritation at application site. No amnesia, withdrawal, or dependence liability — unlike benzodiazepines.

Side effects are generally consistent regardless of the specific application. See our Selank side effects guide for details.

Calculate Your Selank Dose

Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Selank.

Open Calculator →

Bottom Line: Selank for Brain

Selank shows preliminary research potential for brain. Standard protocols (75-300 mcg, 1-3 times daily, 5-21 days with washout periods) apply.

Source from COA-tested vendors and maintain consistent dosing for the full cycle duration.

Complete Guide

Selank: The Anxiolytic Research Peptide

Read the Full Guide →

Related Reading

Research-Grade Sourcing

If you're going to research Selank, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.

Ascension → Browse Selank

Particle → Browse Selank

Limitless → Browse Selank

Frequently Asked Questions

What is Selank?

Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro heptapeptide) is a Nootropic anxiolytic peptide. Developed by the Institute of Molecular Genetics (Russian Academy of Sciences) as a benzodiazepine-like anxiolytic without sedation or dependence. It is researched for anxiety reduction, cognitive enhancement, stress resilience, benzodiazepine-like anxiolysis without dependence.

What is the recommended Selank dosage?

Common dosages: 75-300 mcg administered 1-3 times daily via intranasal spray. Cycle length: 5-21 days with washout periods. Half-life: not established. Use our peptide calculator for exact reconstitution math.

What are the side effects of Selank?

Well-tolerated. Mild nasal irritation at application site. No amnesia, withdrawal, or dependence liability — unlike benzodiazepines.

Is Selank safe?

Selank has shown a favorable safety profile in research. Not FDA-approved. Approved in Russia (2009) for generalized anxiety disorder. Available as research chemical in US. All research should follow appropriate safety protocols.